"Ristocetin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An antibiotic mixture of two components, A and B, obtained from Nocardia lurida (or the same substance produced by any other means). It is no longer used clinically because of its toxicity. It causes platelet agglutination and blood coagulation and is used to assay those functions in vitro.
| Descriptor ID |
D012310
|
| MeSH Number(s) |
D09.400.420.800 D12.644.233.697
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Ristocetin".
Below are MeSH descriptors whose meaning is more specific than "Ristocetin".
This graph shows the total number of publications written about "Ristocetin" by people in this website by year, and whether "Ristocetin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 2 | 0 | 2 |
| 2018 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Ristocetin" by people in Profiles.
-
Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury. J Trauma Acute Care Surg. 2018 11; 85(5):873-880.
-
Laboratory Testing for von Willebrand Factor Ristocetin Cofactor (VWF:RCo). Methods Mol Biol. 2017; 1646:435-451.
-
Ristocetin-Induced Platelet Aggregation (RIPA) and RIPA Mixing Studies. Methods Mol Biol. 2017; 1646:473-494.
-
In-vitro activity of vancomycin, teicoplanin, daptomycin, ramoplanin, MDL 62873 and other agents against staphylococci, enterococci and Clostridium difficile. J Antimicrob Chemother. 1990 Nov; 26(5):627-33.